<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <nonSort>The </nonSort>
    <title>pharmaceutical regulatory process</title>
  </titleInfo>
  <name type="personal">
    <namePart>Berry, Ira R.</namePart>
    <namePart type="date">1942-</namePart>
  </name>
  <name type="personal">
    <namePart>Martin, Robert P. (Robert Paul)</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nyu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York</placeTerm>
    </place>
    <publisher>Informa Healthcare</publisher>
    <dateIssued>c2008 [reprinted 2022]</dateIssued>
    <dateIssued encoding="marc">2022</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>x, 469 pages : illustrations ; 24 cm.</extent>
  </physicalDescription>
  <tableOfContents>Pharmaceutical regulation before and after the Food, Drug, and Cosmetic Act / John P. Swann -- Modernizing the Food And Drug Administration / Arthur Y. Tsien -- The new drug approval- process - before and after 1962 / Michael P. Peskoe -- Generic drug-approval process - Hatch-Waxman update / Marc S. Gross ... [et al.] -- FDA regulation of biological products / Michael S. Labson, Krista Hessler Carver, and Marie C. Boyd -- FDA's antibiotic regulatory scheme : then and now / Irving L. Wiesen -- Generic drugs in a changing intellectual property landscape / Neil F. Greenblum ... [et al.] -- The influence of the Prescription Drug User Fee Act on the approval process / Marc J. Scheineson -- Clinical research requirements for new drug applications / Gary L. Yingling and Ann M. Begley -- Postapproval marketing practices regarding drug safety and pharmacovigilance / Robert P. Martin -- Drugs marketed without FDA approval / Jane Baluss and David Rosen -- FDA regulation of foreign drug imports : the need for improvement / Benjamin L. England.</tableOfContents>
  <tableOfContents>Active pharmaceutical ingredients / Max S. Lazar -- Obtaining approval of new drug applications and abbreviated new drug applications from a chemistry, manufacturing, and controls perspective / Dhiren N. Shah -- Obtaining approval of a generic drug, pre-1984 to the present / Loren Gelber -- New developments in the approval and marketing of nonprescription or OTC drugs / William J. Mead -- Current good manufacturing practice and the drug approval process / Ira R. Berry -- The influence of the USP on the drug approval process / Edward M. Cohen -- Ways, means, and evolving trends in the U.S. registration of drug products from foreign countries / Alberto Grignolo -- Impact of government regulation on prescription drug marketing and promotion / Daniel Glassman, Gene Goldberg, and Barbara Spallitta -- CMC postapproval regulatory affairs : constantly managing change / Leo J. Lucisano, Kevin A. Miller, and Lorien Armour -- Living with 21 CFR part 11 compliance / Richard L. Burcham.</tableOfContents>
  <note type="statement of responsibility">edited by Ira R. Berry, Robert P. Martin.</note>
  <note>Includes bibliographical references and index.</note>
  <note>PHR</note>
  <subject authority="lcsh">
    <topic>Pharmacy</topic>
    <topic>Law and legislation</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Law and legislation</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Legislation, Drug</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Guideline Adherence</topic>
    <topic>legislation &amp; jurisprudence</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Pharmaceutical Preparations</topic>
    <topic>standards</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Pharmacy</topic>
  </subject>
  <classification authority="ddc" edition="23">344.7304233</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Drugs and the pharmaceutical sciences ; v. 185</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">9780367202842</identifier>
  <identifier type="isbn">9781420070422 (hardcover : alk. paper)</identifier>
  <identifier type="lccn">2008042661</identifier>
  <location>
    <physicalLocation>Ayesha Abed Library</physicalLocation>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">BD-DhAAL</recordContentSource>
    <recordCreationDate encoding="marc">220814</recordCreationDate>
    <recordIdentifier source="BD-DhAAL">39349</recordIdentifier>
  </recordInfo>
</mods>
